Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_assertion type Assertion NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_head.
- NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_assertion description "[The introduction of agents that inhibit tumor angiogenesis by targeting vascular endothelial growth factor (VEGF) signaling has made a significant impact on the survival of patients with metastasized renal cell carcinoma (RCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_provenance.
- NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_assertion evidence source_evidence_literature NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_provenance.
- NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_assertion SIO_000772 25446042 NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_provenance.
- NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_assertion wasDerivedFrom befree-2016 NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_provenance.
- NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_assertion wasGeneratedBy ECO_0000203 NP1242056.RAk5IPaR5LrYOGKsP6mHvaeej4C6CQK4XkKLC6wYFxTzY130_provenance.